Modular Medical Statistics
Total Valuation
Modular Medical has a market cap or net worth of $18.18 million. The enterprise value is $15.75 million.
Important Dates
The next estimated earnings date is Monday, June 22, 2026, before market open.
| Earnings Date | Jun 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Modular Medical has 5.41 million shares outstanding. The number of shares has increased by 63.25% in one year.
| Current Share Class | 5.41M |
| Shares Outstanding | 5.41M |
| Shares Change (YoY) | +63.25% |
| Shares Change (QoQ) | +18.63% |
| Owned by Insiders (%) | 2.34% |
| Owned by Institutions (%) | 18.97% |
| Float | 4.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 9.90 |
| PB Ratio | 1.48 |
| P/TBV Ratio | 3.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.09.
| Current Ratio | 1.59 |
| Quick Ratio | 1.35 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -331.77% and return on invested capital (ROIC) is -191.16%.
| Return on Equity (ROE) | -331.77% |
| Return on Assets (ROA) | -149.81% |
| Return on Invested Capital (ROIC) | -191.16% |
| Return on Capital Employed (ROCE) | -332.36% |
| Weighted Average Cost of Capital (WACC) | 4.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$495,907 |
| Employee Count | 54 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Modular Medical has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.45% in the last 52 weeks. The beta is -0.00, so Modular Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.00 |
| 52-Week Price Change | -88.45% |
| 50-Day Moving Average | 4.95 |
| 200-Day Moving Average | 13.26 |
| Relative Strength Index (RSI) | 31.66 |
| Average Volume (20 Days) | 20,167 |
Short Selling Information
The latest short interest is 102,667, so 1.90% of the outstanding shares have been sold short.
| Short Interest | 102,667 |
| Short Previous Month | 122,225 |
| Short % of Shares Out | 1.90% |
| Short % of Float | 2.22% |
| Short Ratio (days to cover) | 1.33 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -26.86M |
| Pretax Income | -26.78M |
| Net Income | -26.78M |
| EBITDA | -25.30M |
| EBIT | -26.86M |
| Earnings Per Share (EPS) | -$14.75 |
Full Income StatementBalance Sheet
The company has $2.94 million in cash and $504,000 in debt, with a net cash position of $2.43 million or $0.45 per share.
| Cash & Cash Equivalents | 2.94M |
| Total Debt | 504,000 |
| Net Cash | 2.43M |
| Net Cash Per Share | $0.45 |
| Equity (Book Value) | 5.88M |
| Book Value Per Share | 2.27 |
| Working Capital | 1.29M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$22.25 million and capital expenditures -$3.88 million, giving a free cash flow of -$26.12 million.
| Operating Cash Flow | -22.25M |
| Capital Expenditures | -3.88M |
| Depreciation & Amortization | 1.56M |
| Net Borrowing | n/a |
| Free Cash Flow | -26.12M |
| FCF Per Share | -$4.83 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Modular Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -63.25% |
| Shareholder Yield | -63.25% |
| Earnings Yield | -147.29% |
| FCF Yield | -143.68% |
Analyst Forecast
The average price target for Modular Medical is $240.00, which is 7,042.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $240.00 |
| Price Target Difference | 7,042.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 31, 2026. It was a reverse split with a ratio of 1:30.
| Last Split Date | Mar 31, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
